During a bout of influenza, B cells interact with other immune cells and then take different paths to defend the body. One path is the B cells that differentiate into antibody producing cells. Another path is the B cells ...
Sep 13, 2023
0
28
One of the remaining mysteries of immunology is the exact mechanism that B cells use to generate millions of antibodies with different specificities to protect us from the plethora of pathogens in the environment.
Sep 7, 2023
0
73
A large team of medical researchers affiliated with several institutions in the U.S., working with pair of colleagues from the University of Ljubljana, in Slovenia, has sequenced the genomes of several hundred samples of ...
With a new flu season upon us, scientists have been testing new ways of fighting the deadly disease with antibody-based therapies—and they've discovered that this approach may be effective in combating influenza B.
Aug 4, 2023
0
21
Researchers from A*STAR's Institute of Molecular and Cell Biology (IMCB) and National Cancer Centre Singapore (NCCS) have discovered how the loss of a gene, PBRM1, can lead to the development of kidney cancer. The work is ...
Jul 28, 2023
0
54
Booster vaccinations (third and fourth vaccinations) of COVID-19 mRNA vaccines that are not adapted to omicron variants do lead to higher blood levels of neutralizing antibodies against the omicron subvariants. However, these ...
Jul 20, 2023
0
20
New insights explaining why some children have a longer remission than others after having cutting-edge CAR T-cell therapy for leukemia have been revealed by researchers at UCL, Great Ormond Street Hospital, and the Wellcome ...
Jul 5, 2023
0
40
In the midst of a global opioid epidemic, a team of scientists is exploring natural killer (NK) cells as an alternative treatment for neuropathic pain. In an Opinion piece published June 27th in the journal Trends in Neurosciences, ...
Jun 27, 2023
0
63
Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. The discovery, published today in Nature Communications, may explain why, even among vulnerable ...
Jun 27, 2023
0
21
In a multicenter phase 3 trial, researchers at the MHH have demonstrated the efficacy and safety of the drug bulevirtide, which prevents HD viruses from entering the liver. This paves the way for a drug therapy of the particularly ...
Jun 22, 2023
0
12
